Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1

BACKGROUND: Prognostic classification of metastatic melanoma patients treated with anti-PD-1 is of great interest to clinicians. OBJECTIVE: We aimed to determine the anti-PD-1 treatment related prognostic performance of demographics, clinical and histological prognostic markers and baseline serum S1...

Descripción completa

Detalles Bibliográficos
Autores principales: Janka, Eszter Anna, Ványai, Beatrix, Szabó, Imre Lőrinc, Toka-Farkas, Tünde, Várvölgyi, Tünde, Kapitány, Anikó, Szegedi, Andrea, Emri, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472446/
https://www.ncbi.nlm.nih.gov/pubmed/37664072
http://dx.doi.org/10.3389/fonc.2023.1237643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472446/
https://www.ncbi.nlm.nih.gov/pubmed/37664072
http://dx.doi.org/10.3389/fonc.2023.1237643

Ejemplares similares